Verónica Rendo

681 total citations
16 papers, 382 citations indexed

About

Verónica Rendo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Verónica Rendo has authored 16 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Verónica Rendo's work include Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Genomics and Diagnostics (4 papers). Verónica Rendo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Genomics and Diagnostics (4 papers). Verónica Rendo collaborates with scholars based in Sweden, United States and Finland. Verónica Rendo's co-authors include Rameen Beroukhim, Aaron R. Thorner, Naomi Currimjee, Anwesha Nag, John G. Doench, Mai Abdusamad, Sangita Pal, Francisca Vázquez, Julian M. Hess and Daniel D. Lam and has published in prestigious journals such as Nature, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Verónica Rendo

15 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Verónica Rendo Sweden	8	315	76	73	60	24	16	382
Sasha Pantel United States	4	303 1.0×	65 0.9×	82 1.1×	29 0.5×	19 0.8×	4	336
Rahmen Bin Ali Netherlands	8	281 0.9×	166 2.2×	82 1.1×	61 1.0×	29 1.2×	9	404
Caroline Huard Canada	12	369 1.2×	71 0.9×	69 0.9×	35 0.6×	15 0.6×	15	438
Holly R. Thomas United States	10	293 0.9×	85 1.1×	58 0.8×	33 0.6×	17 0.7×	14	376
Tuan M. Nguyen United States	10	417 1.3×	72 0.9×	34 0.5×	109 1.8×	18 0.8×	14	500
Meng Lou China	13	328 1.0×	99 1.3×	32 0.4×	93 1.6×	26 1.1×	21	457
Jasper E. Neggers United States	9	337 1.1×	98 1.3×	39 0.5×	63 1.1×	27 1.1×	12	410
Walter F. Lenoir United States	6	275 0.9×	53 0.7×	53 0.7×	33 0.6×	13 0.5×	6	309
Amandine Moretton France	6	290 0.9×	25 0.3×	41 0.6×	27 0.5×	22 0.9×	11	324
Ziyi Wang China	12	322 1.0×	56 0.7×	28 0.4×	167 2.8×	23 1.0×	39	409

Countries citing papers authored by Verónica Rendo

Since Specialization

Citations

This map shows the geographic impact of Verónica Rendo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Rendo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Rendo more than expected).

Fields of papers citing papers by Verónica Rendo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Rendo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Rendo. The network helps show where Verónica Rendo may publish in the future.

Co-authorship network of co-authors of Verónica Rendo

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Rendo. A scholar is included among the top collaborators of Verónica Rendo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Rendo. Verónica Rendo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhang, Xiaonan, et al.. (2025). NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(5). 167755–167755.

Niklasson, Mia, et al.. (2025). p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics. International Journal of Molecular Sciences. 26(9). 3974–3974. 1 indexed citations

Gezelius, Henrik, Anders Lundmark, Amanda Raine, et al.. (2024). Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening. NAR Genomics and Bioinformatics. 6(1). lqae001–lqae001. 5 indexed citations

Zhang, Xiaonan, Lei Zhong, Verónica Rendo, et al.. (2024). Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib. EBioMedicine. 109. 105368–105368. 5 indexed citations

Shih, Juliann, Shahab Sarmashghi, Shu Zhang, et al.. (2023). Cancer aneuploidies are shaped primarily by effects on tumour fitness. Nature. 619(7971). 793–800. 46 indexed citations

Zhang, Xiaonan, Ivaylo Stoimenov, Verónica Rendo, et al.. (2022). Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity. Biochemical Pharmacology. 203. 115184–115184. 2 indexed citations

Rendo, Verónica, Gaofeng Cui, Maria Victoria Botuyan, et al.. (2021). TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs. Molecular Cell. 81(12). 2583–2595.e6. 22 indexed citations

Ali, Muhammad Akhtar, Louis P. Conway, Verónica Rendo, et al.. (2021). Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis. Journal of Experimental & Clinical Cancer Research. 40(1). 225–225. 22 indexed citations

Joyce, Johanna A., et al.. (2021). Women in cancer research and oncology. Cancer Cell. 39(3). 285–287. 1 indexed citations

10.

Enache, Oana M., Verónica Rendo, Mai Abdusamad, et al.. (2020). Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nature Genetics. 52(7). 748–749. 10 indexed citations

11.

Rendo, Verónica, Ivaylo Stoimenov, André Mateus, et al.. (2020). Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy. Nature Communications. 11(1). 1308–1308. 19 indexed citations

12.

Conway, Louis P., et al.. (2020). Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N‐Acetyltransferase NAT2. Angewandte Chemie International Edition. 59(34). 14342–14346. 22 indexed citations

13.

Enache, Oana M., Verónica Rendo, Mai Abdusamad, et al.. (2020). Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nature Genetics. 52(7). 662–668. 206 indexed citations

14.

Rendo, Verónica, Viktor Ljungström, Richard Svensson, et al.. (2020). Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer. Scientific Reports. 10(1). 22436–22436. 5 indexed citations

15.

Conway, Louis P., et al.. (2020). Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N‐Acetyltransferase NAT2. Angewandte Chemie. 132(34). 14448–14452. 2 indexed citations

16.

Pandzic, Tatjana, Verónica Rendo, Jinyeong Lim, et al.. (2017). Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth. Oncotarget. 8(58). 98646–98659. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact